HKU Scholars Hub: Browsing DSpace

Browsing by Author de Haan, L

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 15 of 15

	Title	Author(s)	Issue Date	Views
	Basic symptoms in young people at ultra-high risk of psychosis: Association with clinical characteristics and outcomes Journal:Schizophrenia Research	Youn, S Phillips, LJ Amminger, GP Berger, G Chen, EYH de Haan, L Hartmann, JA Hickie, IB Lavoie, S Markulev, C McGorry, PD Mossaheb, N Nieman, DH Nordentoft, M Riecher-Rössler, A Schäfer, MR Schlögelhofer, M Smesny, S Thompson, A Verma, S Yuen, HP Yung, AR Nelson, B	2020	16
	Cognitive functioning in ultra-high risk for psychosis individuals with and without depression: Secondary analysis of findings from the NEURAPRO randomized clinical trial Journal:Schizophrenia Research	Mallawaarachchi, SR Amminger, GP Farhall, J Bolt, LK Nelson, B Yuen, HP McGorry, PD Markulev, C Schäfer, MR Mossaheb, N Schlögelhofer, M Smesny, S Hickie, IB Berger, GE Chen, EYH de Haan, L Nieman, DH Nordentoft, M Riecher-Rössler, A Verma, S Thompson, A Yung, AR Allott, KA	2020	29
	Common variants conferring risk of schizophrenia Journal:Nature	Stefansson, H Ophoff, RA Steinberg, S Andreassen, OA Cichon, S Rujescu, D Werge, T Pietiläinen, OPH Mors, O Mortensen, PB Sigurdsson, E Gustafsson, O Nyegaard, M TuulioHenriksson, A Ingason, A Hansen, T Suvisaari, J Lonnqvist, J Paunio, T Børglum, AD Hartmann, A FinkJensen, A Nordentoft, M Hougaard, D NorgaardPedersen, B Böttcher, Y Olesen, J Breuer, R Möller, HJ Giegling, I Rasmussen, HB Timm, S Mattheisen, M Bitter, I Réthelyi, JM Magnusdottir, BB Sigmundsson, T Olason, P Masson, G Gulcher, JR Haraldsson, M Fossdal, R Thorgeirsson, TE Thorsteinsdottir, U Ruggeri, M Tosato, S Franke, B Strengman, E Kiemeney, LA Melle, I Djurovic, S Abramova, L Kaleda, V Sanjuan, J De Frutos, R Bramon, E Vassos, E Fraser, G Ettinger, U Picchioni, M Walker, N Toulopoulou, T Need, AC Ge, D Lim Yoon, J Shianna, KV Freimer, NB Cantor, RM Murray, R Kong, A Golimbet, V Carracedo, A Arango, C Costas, J Jönsson, EG Terenius, L Agartz, I Petursson, H Nöthen, MM Rietschel, M Matthews, PM Muglia, P Peltonen, L St Clair, D Goldstein, DB Stefansson, K Collier, DA Kahn, RS Linszen, DH Van Os, J Wiersma, D Bruggeman, R Cahn, W De Haan, L Krabbendam, L MyinGermeys, I	2009	185
	Comparison of erythrocyte omega-3 index, fatty acids and molecular phospholipid species in people at ultra-high risk of developing psychosis and healthy people Journal:Schizophrenia Research	Alqarni, A Mitchell, TW McGorry, PD Nelson, B Markulev, C Yuen, HP Schäfer, MR Berger, M Mossaheb, N Schlögelhofer, M Smesny, S Hickie, IB Berger, GE Chen, EYH de Haan, L Nieman, DH Nordentoft, M Riecher-Rössler, A Verma, S Thompson, A Yung, AR Amminger, GP Meyer, BJ	2020	16
	Disruption of the neurexin 1 gene is associated with schizophrenia Journal:Human Molecular Genetics	Rujescu, D Ingason, A Cichon, S Pietiläinen, OPH Barnes, MR Toulopoulou, T Picchioni, M Vassos, E Ettinger, U Bramon, E Murray, R Ruggeri, M Tosato, S Bonetto, C Steinberg, S Sigurdsson, E Sigmundsson, T Petursson, H Gylfason, A Olason, PI Hardarsson, G Jonsdottir, GA Gustafsson, O Fossdal, R Giegling, I Möller, HJ Hartmann, AM Hoffmann, P Crombie, C Fraser, G Walker, N Lonnqvist, J Suvisaari, J TuulioHenriksson, A Djurovic, S Melle, I Andreassen, OA Hansen, T Werge, T Kiemeney, LA Franke, B Veltman, J BuizerVoskamp, JE Sabatti, C Ophoff, RA Rietschel, M Nöthen, MM Stefansson, K Peltonen, L St Clair, D Stefansson, H Collier, DA Kahn, RS Linszen, D von Os, J Wiersma, D Bruggeman, R Cahn, W de Haan, L Krabbendam, L MyinGermeys, I	2009	117
	Distress related to attenuated psychotic symptoms: Static and dynamic association with transition to psychosis, non-remission and transdiagnostic symptomatology in clinical high-risk patients in an international intervention trial Journal:Schizophrenia Bulletin Open	Nelson, B Yuen, HP Amminger, GP Berger, G Chen, EYH de Haan, L Hartmann, JA Hickie, IB Lavoie, S Markulev, C Mossaheb, N Nieman, DH Nordentoft, M Polari, A Riecher-Rössler, A Schäfe, MR Schlögelhofer, M Smesny, S Tedja, A Thompson, A Verma, S Yung, AR McGorry, PD	2020	15
	Do schizotypal or borderline personality disorders predict onset of psychotic disorder or persistent attenuated psychotic symptoms in patients at high clinical risk? Journal:Schizophrenia Research	Hadar, H Zhang, H Phillips, LJ Amminger, GP Berger, GE Chen, EYH de Haan, L Hartmann, JA Hickie, IB Lavoie, S Markulev, C McGorry, PD Mossaheb, N Nieman, DH Nordentoft, M Riecher-Rössler, A Schäfer, MR Schlögelhofer, M Smesny, S Thompson, A Verma, S Yuen, HP Yung, AR Nelson, B	2020	15
	Jumping to conclusions, general intelligence, and psychosis liability: findings from the multi-centre EU-GEI case-control study Journal:Psychological Medicine	Tripoli, G Quattrone, D Ferraro, L Gayer-Anderson, C Rodriguez, V La Cascia, C La Barbera, D Sartorio, C Seminerio, F Tarricone, I Berardi, D Szöke, A Arango, C Tortelli, A Llorca, PM de Haan, L Velthorst, E Bobes, J Bernardo, M Sanjuán, J Santos, JL Arrojo, M Del-Ben, CM Menezes, PR Selten, JP Jones, PB Jongsma, HE Kirkbride, JB Lasalvia, A Tosato, S Richards, A O’Donovan, M Rutten, BPF Qs, JV Morgan, C Sham, PC Murray, RM Murray, GK Di Forti, M EU-GEI WP2 Group,	2021	20
	Large recurrent microdeletions associated with schizophrenia Journal:Nature	Stefansson, H Rujescu, D Cichon, S Pietiläinen, OPH Ingason, A Steinberg, S Fossdal, R Sigurdsson, E Sigmundsson, T BuizerVoskamp, JE Hansen, T Jakobsen, KD Muglia, P Francks, C Matthews, PM Gylfason, A Halldorsson, BV Gudbjartsson, D Thorgeirsson, TE Sigurdsson, A Jonasdottir, A Jonasdottir, A Bjornsson, A Mattiasdottir, S Blondal, T Haraldsson, M Magnusdottir, BB Giegling, I Möller, HJ Hartmann, A Shianna, KV Ge, D Need, AC Crombie, C Fraser, G Walker, N Lonnqvist, J Suvisaari, J TuulioHenriksson, A Paunio, T Toulopoulou, T Bramon, E Di Forti, M Murray, R Ruggeri, M Vassos, E Tosato, S Walshe, M Li, T Vasilescu, C Mühleisen, TW Wang, AG Ullum, H Djurovic, S Melle, I Olesen, J Kiemeney, LA Franke, B Sabatti, C Freimer, NB Gulcher, JR Thorsteinsdottir, U Kong, A Andreassen, OA Ophoff, RA Georgi, A Rietschel, M Werge, T Petursson, H Goldstein, DB Nöthen, MM Peltonen, L Collier, DA St Clair, D Stefansson, K Kahn, RS Linszen, DH Van Os, J Wiersma, D Bruggeman, R Cahn, W De Haan, L Krabbendam, L MyinGermeys, I	2008	162
	Neurocognition as a predictor of transition to psychotic disorder and functional outcomes in ultra-high risk participants: Findings from the NEURAPRO randomized clinical trial Journal:Schizophrenia Research	Bolt, LK Amminger, GP Farhall, J McGorry, PD Nelson, B Markulev, C Yuen, HP Schäfer, MR Mossaheb, N Schlögelhofer, M Smesny, S Hickie, IB Berger, GE Chen, EYH de Haan, L Nieman, DH Nordentoft, M Riecher-Rössler, A Verma, S Thompson, A Yung, AR Allott, KA	2019	11
	Omega‐3 fatty acids and neurocognitive ability in young people at ultra‐high risk for psychosis Journal:Early Intervention in Psychiatry	McLaverty, A Allott, KA Berger, M Hester, R McGorry, PD Nelson, B Markulev, C Yuen, HP Schäfer, MR Mossaheb, N Schlögelhofer, M Smesny, S Hickie, IB Berger, GE Chen, EYH de Haan, L Nieman, DH Nordentoft, M Riecher‐Rössler, A Verma, S Thompson, A Yung, AR Amminger, GP	2020	12
	Opening the Black Box of Cognitive-Behavioural Case Management in Clients with Ultra-High Risk for Psychosis Journal:Psychotherapy and Psychosomatics	Hartmann, JA McGorry, P Schmidt, S Amminger, P Yuen, HP Markuley, C Berger, GE Chen, EYH de Haan, L Hickie, IB Lavoie, S McHugh, MJ Mossaheb, N Nieman, DH Nordentoft, M Riecher-Rössler, A Schäfer, MR Schlögelhofer, M Smesny, S Thompson, A Verma, SK Yung, A Nelson, B	2017	83
	Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical Trial Journal:Frontiers in Psychiatry	Berger, M Nelson, B Markulev, C Yuen, HP Schäfer, MR Mossaheb, N Schlögelhofer, M Smesny, S Hickie, IB Berger, GE Chen, EYH de Haan, L Nieman, DH Nordentoft, M Riecher-Rössler, A Verma, S Mitchell, TW Meyer, BJ Thompson, A Yung, AR McGorry, PD Amminger, GP	2019	13
	The NEURAPRO Biomarker Analysis: Long-Chain Omega-3 Fatty Acids Improve 6-Month and 12-Month Outcomes in Youths at Ultra-High Risk for Psychosis Journal:Biological Psychiatry	Amminger, GP Nelson, B Markulev, C Yuen, HP Schäfer, MR Berger, M Mossaheb, N Schlögelhofer, M Smesny, S Hickie, IB Berger, GE Chen, EYH de Haan, L Nieman, DH Nordentoft, M Riecher-Rössler,, A Verma, S Thompson, A Yung, AR McGorry, PD	2020	11
	Trajectories of symptom severity and functioning over a three-year period in a psychosis high-risk sample: A secondary analysis of the Neurapro trial Journal:Behaviour Research and Therapy	Hartmann, JA Schmidt, SJ McGorry, PD Berger, M Berger, GE Chen, EYH de Haan, L Hickie, IB Lavoie, S Markule, C Mossaheb, N Nieman, DH Nordentoft, M Polari, A Riecher-Rössler, A Schäfer, MR Schlögelhofer, M Smesny, S Thompson, A Verma, SK Yuen, HP Yung, AR Amminger, GP Nelson, B	2020	15

Showing results 1 to 15 of 15